French businessman
AstraZeneca should stick to its winning formula. It doesn’t need a $400bn US mega-merger
theguardian.com/business/2026/aug/03/astrazeneca-should-stick-to-winning-formula-doesnt-need-400bn-us-mega-merger
Pharmaceutical giant: AstraZeneca considers $400 billion merger with Bristol Myers
manager-magazin.de/unternehmen/industrie/astrazeneca-pharmakonzern-prueft-400-milliarden-dollar-fusion-mit-bristol-myers-a-7e61b544-f400-43be-9d2c-f9b10e60a448
Prozess um brutale Schlägerei in Hannovers Rotlichtviertel: Türsteher zu Bewährungsstrafe verurteilt
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-magic-faces-rare-test-after-trial-failure-share-slide-2026-07-24/
Paid articlePaywall AstraZeneca sticks to $80 billion sales target for 2030: Sir Pascal Soriot, the chief executive of the pharmaceutical company, says the forecast ‘assumes ...
thetimes.com/business/companies-markets/article/astrazeneca-sticks-to-80-billion-sales-target-for-2030-jbhfscfk5
AstraZeneca CEO Pascal Soriot delivers remarks as firm celebrates transfer to NYSE
qz.com/astrazeneca-ceo-pascal-soriot-nyse-transfer
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
cnbc.com/2026/06/05/astrazeneca-ceo-says-ai-is-reshaping-drug-development-and-helping-boost-the-odds-of-success.html
AstraZeneca CEO: “If prices are too low, we won’t bring the drugs to market”: Pascal Soriot, CEO of the pharmaceutical company AstraZeneca, is threatening to ...
wiwo.de/unternehmen/industrie/astrazeneca-chef-sind-die-preise-zu-niedrig-bringen-wir-die-medikamente-nicht-auf-den-markt/100218667.html
NHS won’t get cutting-edge drugs unless it pays more, says AstraZeneca boss: Pascal Soriot says cost-effectiveness thresholds for new medicines have not changed ...
theguardian.com/business/2025/nov/06/uk-will-only-be-able-to-afford-generic-drugs-if-nhs-fails-to-pay-more-says-astrazeneca-boss
Dividend guarantor AstraZeneca keeps growing – pharmaceutical giant on track: AstraZeneca exceeds expectations with Q3 growth and confirms targets for 2030.
deraktionaer.de/artikel/pharma-biotech/dividenden-garant-astrazeneca-waechst-und-waechst-pharma-riese-auf-kurs-20389877.html
Trump reveals prescription drug deal with pharmaceutical giant AstraZeneca: The US president told reporters he didn’t think the deal would have been possible ...
aljazeera.com/news/2025/10/10/trump-reveals-prescription-drug-deal-with-pharmaceutical-giant-astrazeneca
The Times and The Sunday Times Oct 04 25
Paid articlePaywall Starmer spoke with AstraZeneca boss before listing move to US: The prime minister hosted Sir Pascal Soriot last month amid worries about the City as the UK’s ...
thetimes.com/business-money/companies/article/keir-starmer-astrazeneca-ceo-pascal-soriot-tnk8np7sc
“What we have seen in China is really, a substantial return of scientists from the US, but also from the UK and elsewhere, but not because of policy ... Show more
Paid articlePaywall AstraZeneca Loses Spot as UK’s Most Valuable Company to HSBC: AstraZeneca Plc lost its crown as the UK’s most valuable listed company after US President Donald ...
bloomberg.com/news/articles/2025-05-12/astrazeneca-loses-spot-as-uk-s-most-valuable-company-to-hsbc
AstraZeneca to invest $2.5 billion in Beijing hub as it looks beyond Chinese tax probe
cnbc.com/2025/03/21/british-pharma-giant-astrazeneca-to-invest-2point5-billion-in-new-china-hub.html
Paid articlePaywall Europe Rapidly Falling Behind China in Pharma, Astra Chief Warns: Europe is fast losing its edge to China in pharmaceutical innovation, AstraZeneca Plc Chief ...
bloomberg.com/news/articles/2025-03-26/europe-rapidly-falling-behind-china-in-pharma-astra-chief-warns
Governments need centralized AI centers with accurate data for better public services, say business leaders
arabnews.com/node/2589926/middle-east
trib.al Nov 12 24
Astra’s Triple Shot: Get briefed ahead of your morning calls with the latest UK business headlines, key data and market reaction
bloomberg.com/news/newsletters/2024-11-12/astra-s-triple-shot
AstraZeneca Says Obesity Pill Well-Tolerated, Highly Competitive: AstraZeneca Plc said its experimental obesity pill was well tolerated by patients with type-2 ...
bloomberg.com/news/articles/2024-11-04/astrazeneca-says-obesity-pill-well-tolerated-highly-competitive
trib.al Sep 13 24
Paid articlePaywall AstraZeneca Shares Set For Worst Week in 14 Months on Sell Calls: AstraZeneca Plc shares are on track for their biggest weekly decline since July 2023 ...
bloomberg.com/news/articles/2024-09-13/astrazeneca-shares-set-for-worst-week-in-14-months-on-sell-calls
Drug maker AstraZeneca becomes Britain’s record breaking first £200bn company: Development of blockbuster drugs to combat cancer and other diseases makes it the ...
inews.co.uk/news/business/record-astrazeneca-britains-200bn-company-3226191
Paid articlePaywall Jamie Dimon's Crack at Shadowy Proxy Firms Is Resonating: Regulatory interest in businesses advising on shareholder votes is picking up in the UK after ...
bloomberg.com/opinion/articles/2024-07-25/jamie-dimon-s-crack-at-shadowy-proxy-firms-is-resonating
trib.al Jul 25 24
AstraZeneca’s Pascal Soriot: Britain’s Access to New Drugs Could Totally Shrink: AstraZeneca Plc Chief Executive Officer Pascal Soriot has a warning for ...
bloomberg.com/news/articles/2024-07-25/astrazeneca-s-pascal-soriot-britain-s-access-to-new-drugs-could-totally-shrink
AstraZeneca’s next big target can cement its sector darling status: Pharma group believes successful medicines from its clinical trials could generate $20bn in ...
ft.com/content/9b2238eb-0a5b-4315-bc57-c4f74ce1ce37
Paid articlePaywall AstraZeneca (AZN) Aims for $80 Billion in Sales by 2030: AstraZeneca Plc aims to almost double sales to $80 billion by 2030 as Chief Executive Officer Pascal ...
bloomberg.com/news/articles/2024-05-21/astrazeneca-aims-for-80-billion-in-sales-by-2030
Key FactsAstraZeneca Aims to Nearly Double Revenues by 2030
May 21, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: theguardian.com
Summary created with AI assistance · Source: theguardian.com
- Britain’s biggest drugmaker, AstraZeneca, aims to achieve $80 billion in revenues by 2030 from treatments for cancer, rare diseases, and other conditions.
- Presenting growth plans to shareholders in Cambridge, England, CEO Pascal Soriot stated that 12 of the 20 new drugs have the potential to generate over $5 billion in annual revenues, including five cancer treatments.
- AstraZeneca has revamped its drugs pipeline and developed a strong portfolio of cancer, cardiovascular, metabolic, respiratory, and rare disease medicines.
- The company announced plans to build a new factory in Singapore for manufacturing a new generation of cancer-killing drugs and is entering the weight-loss drug market with an obesity and diabetes pill licensed from China.
Paid articlePaywall Is any CEO worth the £18.7m AstraZeneca wants to pay boss Pascal Soriot?: Pascal Soriot was already the highest-paid leader of a FTSE 100 company ...
independent.co.uk/independentpremium/business/astrazeneca-salary-pascal-soriot-b2527111.html
AstraZeneca CEO set to earn £18.7 million after shareholder backing: More than 60% of shareholders backed the decision to raise Pascal Soriot’s pay packet ...
euronews.com/business/2024/04/12/astrazeneca-ceo-set-to-earn-187-million-after-shareholder-backing
AstraZeneca promises dividend increase ahead of key vote on chief’s pay: Pharma group proposes raising pay for Pascal Soriot up to £18.7mn
ft.com/content/5b88670f-1e29-45f5-b6d7-6c0157bcd427
Proxy advisers inflict ‘serious harm’ to UK, says AstraZeneca chair : Michel Demaré in FT hits out at ISS and Glass Lewis for applying ‘double standards’ after ...
ft.com/content/838177cd-af87-4b86-ac47-ecfc45665020
Paid articlePaywall AstraZeneca Says Imfinzi Lung Cancer Drug Improved Survival: AstraZeneca Plc’s lung cancer drug improved survival in patients with a highly aggressive form of ...
bloomberg.com/news/articles/2024-04-05/astrazeneca-says-key-lung-cancer-drug-improved-survival
Key FactsAstraZeneca's Imfinzi Shows Promise in Treating Aggressive Lung Cancer
Apr 5, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: reuters.com
Summary created with AI assistance · Source: reuters.com
- AstraZeneca announced that their cancer drug Imfinzi helps improve overall and progression-free survival in patients with limited-stage small cell lung cancer.
- In a late-stage trial, the drug demonstrated a statistically significant and clinically meaningful improvement in the dual primary goals of overall survival and progression-free survival.
- Small cell lung cancer is recognized for its high level of aggressiveness and rapid disease progression despite initial treatment with chemotherapy and radiotherapy.
- Imfinzi is part of the Anglo-Swedish drugmaker's key cancer portfolio and accounted for 23% of total group revenue last year.
AstraZeneca CEO Pascal Soriot’s £17m pay package under fire: Governance thinktank asks whether he has earned a hundred times that of many of his employees
theguardian.com/business/2024/feb/20/astrazeneca-ceo-pascal-soriot-17m-pay-makes-him-one-of-best-paid-ftse-100-bosses
/cloudfront-us-east-2.images.arcpublishing.com/reuters/4K7KWUIVNRP43LCJ3JZMZHB5GQ.jpg)
Astrazeneca says Catalent deal shows need for in-house capacity: The sale of listed contract drugmaker Catalent (CTLT.N) to the parent of Novo Nordisk (NOVOb ...
reuters.com/markets/deals/astrazeneca-says-catalent-deal-shows-importance-in-house-capacity-2024-02-08/
trib.al Feb 08 24
Paid articlePaywall AstraZeneca CEO Soriot Says Market Access Is Turning Pharma Off the UK: Hurdles in bringing drugs to market in the UK is putting pharmaceutical companies off ...
bloomberg.com/news/articles/2024-02-08/astra-ceo-soriot-says-market-access-is-turning-pharma-off-the-uk
Paid articlePaywall AstraZeneca (AZN) Sees Stronger Profit, Sales Growth on Cancer Drugs: AstraZeneca Plc reported lower-than-expected profit and a forecast for this year that ...
bloomberg.com/news/articles/2024-02-08/astra-sees-stronger-profit-sales-growth-on-cancer-drugs